Association of increased reactive oxygen species production with abdominal obesity in type 2 diabetes

Obesity Research and Clinical Practice

Volumn 4, Issue 2, 2010, Pages

  Hirao, K ^a   Maruyama, T ^a   Ohno, Y ^a   Hirose, H ^a   Shimada, A ^a   Takei, I ^b   Murata, M ^a   Morii, T ^a   Eguchi, T ^a   Hayashi, M ^a   Saruta, T ^a   Itoh, H ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO DENTAL COLLEGE   (Japan)

Author keywords

Abdominal obesity; Metabolic syndrome; Oxidative stress; Reactive oxygen species; Type 2 diabetes

Indexed keywords

ARACHIDONIC ACID; LUCIFERIN; PHORBOL 13 ACETATE 12 MYRISTATE; REACTIVE OXYGEN METABOLITE;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BODY MASS; CELL IMMORTALIZATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; INSULIN RESISTANCE; LYMPHOBLAST; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

CYPRIDINA LUCIFERIN; HUMAN HERPESVIRUS 4;

EID: 77956705387     PISSN: 1871403X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.orcp.2009.09.004     Document Type: Article

References (49)

1. A.H. Mokdad, B.A. Bowman, E.S. Ford, F. Vinicor, J.S. Marks, and J.P. Koplan The continuing epidemics of obesity and diabetes in the United States JAMA 286 2001 1195 1200
2. S. Haffner, and H. Taegtmeyer Epidemic obesity and the metabolic syndrome Circulation 108 2003 1541 1545
3. H.B. Hubert, M. Feinleib, P.M. McNamara, and W.P. Castelli Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study Circulation 67 1983 968 977
4. S.M. Grundy, B. Hansen, S.C. Smith Jr., J.I. Cleeman, R.A. Kahn American Heart Association; National Heart, Lung, and Blood Institute; American Diabetes Association Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management Circulation 109 2004 551 556
5. I. Shimomura, T. Funahashi, M. Takahashi, K. Maeda, K. Kotani, and T. Nakamura Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity Nat Med 2 1996 800 803
6. G.S. Hotamisligil, N.S. Shargill, and B.M. Spiegelman Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance Science 259 1993 87 91
7. S.K. Fried, D.A. Bunkin, and A.S. Greenberg Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid J Clin Endocrinol Metab 83 1998 847 850
8. P. Sartipy, and D.J. Loskutoff Monocyte chemoattractant protein 1 in obesity and insulin resistance Proc Natl Acad Sci USA 100 2003 7265 7270
9. I. Hainault, G. Nebout, S. Turban, B. Ardouin, P. Ferre, and A. Quignard-Boulange Adipose tissue-specific increase in angiotensinogen expression and secretion in the obese (fa/fa) zucker rat Am J Physiol Endocrinol Metab 282 2002 E59 E66
10. Y. Matsuzawa, T. Funahashi, S. Kihara, and I. Shimomura Adiponectin and metabolic syndrome Arterioscler Thromb Vasc Biol 24 2004 29 33
11. I.S. Farooqi, J.M. Keogh, S. Kamath, S. Jones, W.T. Gibson, and R. Trussell Partial leptin deficiency and human adiposity Nature 414 2001 34 35
12. K.M. Pou, J.M. Massaro, U. Hoffmann, R.S. Vasan, P. Maurovich-Horvat, and M.G. Larson Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study Circulation 116 2007 1234 1241
13. T. Nakagami, Q. Qiao, B. Carstensen, C. Nhr-Hansen, G. Hu, and J. Tuomilehto Age, body mass index and Type 2 diabetes-associations modified by ethnicity Diabetologia 46 2003 1063 1070
14. F. Conus, R. Rabasa-Lhoret, and F. Péronnet Characteristics of metabolically obese normal-weight (MONW) subjects Appl Physiol Nutr Metab 32 2007 4 12
15. J.B. Meigs, P.W. Wilson, C.S. Fox, R.S. Vasan, D.M. Nathan, and L.M. Sullivan Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease J Clin Endocrinol Metab 91 2006 2906 2912
16. M. Brochu, A. Tchernof, I.J. Dionne, C.K. Sites, G.H. Eltabbakh, and E.A. Sims What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 86 2001 1020 1025
17. N.B. Ruderman, S.H. Schneider, and P. Berchtold The metabolically-obese, normal-weight individual Am J Clin Nutr 34 1981 1617 1621
18. N. Ruderman, D. Chisholm, X. Pi-Sunyer, and S. Schneider The metabolically obese, normal-weight individual revisited Diabetes 47 1998 699 713
19. R.V. Dvorak, W.F. DeNino, P.A. Ades, and E.T. Poehlman Phenotypic characteristics associated with insulin resistance in metabolically obese but normal weight young women Diabetes 48 1999 2210 2214
20. M.P. St-Onge, I. Janssen, and S.B. Heymsfield Metabolic syndrome in normal weight Americans: new definition of the metabolically obese, normal-weight individual Diabetes Care 27 2004 2222 2228
21. A. Katsuki, Y. Sumida, H. Urakawa, E.C. Gabazza, S. Murashima, and K. Nakatani Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance Diabetes Care 26 2003 2341 2344 (Pubitemid 36993323)
22. Y. Matsuzawa The metabolic syndrome and adipocytokines FEBS Lett 580 2006 2917 2921
23. A.I. Pettit, R.K. Wong, V. Lee, S. Jennings, P.A. Quinn, and L.L. Ng Increased free radical production in hypertension due to increased expression of the NADPH oxidase subunit p22 (phox) in lymphoblast cell lines J Hypertens 20 2002 677 683
24. J. Redon, M.R. Oliva, C. Tormos, V. Giner, J. Chaves, and A. Iradi Antioxidant activities and oxidative stress byproducts in human hypertension Hypertension 41 2003 1096 1101
25. Y. Ohno, H. Suzuki, H. Yamakawa, M. Nakamura, K. Otsuka, and T. Saruta Impaired insulin sensitivity in young, lean normotensive offspring of essential hypertensives: possible role of disturbed calcium metabolism J Hypertens 11 1993 421 426
26. T. Morii, Y. Ohno, H. Hirose, H. Kawabe, T. Ogata, and K. Hirao Cellular insulin resistance in Epstein-Barr virus-transformed lymphoblasts from young insulin-resistant Japanese men Metabolism 54 2005 370 375
27. S.I. Taylor, B. Samuels, J. Roth, M. Kasuge, J.A. Hedo, and P. Gorden Decreased insulin binding in cultured lymphocytes from two patients with extreme insulin resistance J Clin Endocrinol Metab 54 1982 919 930
28. Committee on Evaluation of Diagnostic Standards for Metabolic Syndrome Definition and diagnostic standards for metabolic syndrome Nippon Naika Gakkai Zasshi The Journal of the Japanese Society of Internal Medicine 94 2005 794 809 [in Japanese]
29. Examination Committee of Criteria for 'Obesity Disease' in Japan Japan society for the study of obesity. New criteria for 'obesity disease' in Japan Circ J 66 2002 987 992
30. G. Sesti, M.A. Marini, A. Montemurro, L. Condorelli, P. Borboni, and H.U. Haring Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct Diabetes 41 1992 6 11
31. P.J. Hartfield, and J.M. Robinson Arachidonic acid activates NADPH oxidase by a direct, calmodulin-regulated mechanism Prostaglandins Other Lipid Mediat 56 1998 1 6
32. K.M. Mohazzab, P.M. Kaminski, and M.S. Wolin NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium Am J Physiol 266 1994 H2568 H2572
33. L. Liu, C. Dahlgren, H. Elwing, and H. Lundqvist A simple chemiluminescence assay for determination of reactive oxygen species produced by human neutrophils J Immunol Methods 192 1996 173 178
34. - Anal Biochem 159 1986 363 369
35. - production in phagocytizing macrophages FEBS Lett 197 1986 27 30
36. S. Tsugane, S. Sasaki, and Y. Tsubono Under- and overweight impact on mortality among middle-aged Japanese men and women: a 10-y follow-up of JPHC study cohort I Int J Obes Relat Metab Disord 26 2002 529 537
37. S.P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Jr. Obesity is associated with macrophage accumulation in adipose tissue J Clin Invest 112 2003 1796 1808
38. H. Xu, G.T. Barnes, Q. Yang, G. Tan, D. Yang, and C.J. Chou Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance J Clin Invest 112 2003 1821 1830
39. J.N. Fain, A.K. Madan, M.L. Hiler, P. Cheema, and S.W. Bahouth Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans Endocrinology 145 2004 2273 2282
40. T. Hayashi, E.J. Boyko, M.J. McNeely, D.L. Leonetti, S.E. Kahn, and W.Y. Fujimoto Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans Diabetes 57 2008 1269 1275
41. E. Succurro, M.A. Marini, S. Frontoni, M.L. Hribal, F. Andreozzi, and R. Lauro Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals Obesity 16 2008 1881 1886
42. K.C. Chiu, P. Cohan, N.P. Lee, and L.M. Chuang Insulin sensitivity differs among ethnic groups with a compensatory response in beta-cell function Diabetes Care 23 2000 1353 1358
43. + antiporter phenotype, abundance and phosphorylation of immortalized B lymphocytes from humans with hypertension Hypertension 25 1995 971 977
44. J. Nishihira, and J.T. O'Flaherty Phorbol myristate acetate receptors in human polymorphonuclear neutrophils J Immunol 135 1985 3439 3447
45. - generating oxidase of B lymphocytes: Epstein-Barr virus-immortalized B lymphocytes as a tool for the identification of defective components of the oxidase in chronic granulomatous disease Biochim Biophys Acta 1182 1993 101 109
46. K.K. Griendling, C.A. Minieri, J.D. Ollerenshaw, and R.W. Alexande Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells Circ Res 74 1994 1141 1148
47. S. Rajagopalan, S. Kurz, T. Munzel, M. Tarpey, B.A. Freeman, and K.K. Griendling Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NAD/NADPH oxidase activation J Clin Invest 97 1996 1916 1923
48. T. Inoguchi, P. Li, F. Umeda, H.Y. Yu, M. Kakimoto, and M. Imamura High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells Diabetes 49 2000 1939 1945
49. H.E. Bays, J.M. González-Campoy, G.A. Bray, A.E. Kitabchi, D.A. Bergman, and A.B. Schorr Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity Expert Rev Cardiovasc Ther 6 2008 343 368